Eli Lilly Pharmaceutical Company
Eli Lilly and Co. is a pharmaceutical company that was founded in 1876 by Colonel Eli Lilly.4 Its first major breakthrough was the development of gelatin coating for pills, which later turned into the gelatin capsules. Since 1876 Eli Lilly and Co. has been a pioneer in the pharmaceutical industry.5 The main focus of Lilly is the research and development of neuroscience and endocrinology drugs. They have expanded their operations over time into over 60 nations worldwide. The pharmaceutical sector brings in sales of $1 trillion every year.10
Products While Eli Lilly makes and sells numerous drugs their 5 biggest sellers are Zyprexa, Gemzar, Humalog, Evista, and Humulin, in that order. These five drugs account for 60% of Lilly's net …show more content…
has indicated its intent to reduce its stock in Eli Lilly and Co. by $2 Billion. The endowment is the largest shareholder in Eli Lilly. The sell off is intended to diversify the endowments assets and decrease the risk to its assets. This sell off adversely affects Eli Lilly's main anti-takeover provision. The endowment stake in Eli Lilly will decrease to 10.6% after the sell off.7 Eli Lilly and their partner Amylin Pharmaceuticals Inc. have announced that they are having difficulty meeting manufacturing capability for their diabetes drug Byetta. Medical representatives for the company have stopped giving out free samples to the doctors they serve. Advertising for Byetta had ceased and will not resume until production can be brought up to acceptable levels. Byetta generated $68 million in sales for Q1 2006.8 Lilly is planning on reorganizing its approach to selling drugs in the US. It will decrease the number of sales reps it employs and shift its focus towards building deeper relationships with individual physicians. It is expected that this reorganization will help Eli Lilly's sales …show more content…
http://www.lilly.com/products/index.html
This site is an official Eli Lilly website. It lays out all of Lilly's products and their uses.
2. http://investor.lilly.com/pipeline.cfm
This is an official Eli Lilly website. It lays out all of Eli Lilly's current drug submissions to the FDA and all drugs currently going through different FDA testing.
3. Eli Lilly. (2005). 2005 Annual Report to Shareholders. Retrieved October 20, 2005.
This is Eli Lilly's annual stockholders report. It reports on the financial data of the company for 2005, and gives predictions of its performance in 2006.
4. Quick, Amanda C., ed. Company Profiles for Students. Michigan: Gale, 2002.
This source gives financial information on Eli Lilly for 2002. It was useful in compiling a history of the company.
5. Sutton, George, ed. Hoover's Handbook of American Businesses 2002. Texas: Hoover's Business Press, 2002.
This source gives financial information on Eli Lilly for 2002. It was useful in compiling a history of the company.
6. Chuvala, Bob. (2006, August 14). Blockbuster for Biodel. Fairfield County Business Journal (Indiana). Vol. 45 No. 33 pp 1-2. Retrieved October 20, 2006 fromEBSCO Host Research
Products While Eli Lilly makes and sells numerous drugs their 5 biggest sellers are Zyprexa, Gemzar, Humalog, Evista, and Humulin, in that order. These five drugs account for 60% of Lilly's net …show more content…
has indicated its intent to reduce its stock in Eli Lilly and Co. by $2 Billion. The endowment is the largest shareholder in Eli Lilly. The sell off is intended to diversify the endowments assets and decrease the risk to its assets. This sell off adversely affects Eli Lilly's main anti-takeover provision. The endowment stake in Eli Lilly will decrease to 10.6% after the sell off.7 Eli Lilly and their partner Amylin Pharmaceuticals Inc. have announced that they are having difficulty meeting manufacturing capability for their diabetes drug Byetta. Medical representatives for the company have stopped giving out free samples to the doctors they serve. Advertising for Byetta had ceased and will not resume until production can be brought up to acceptable levels. Byetta generated $68 million in sales for Q1 2006.8 Lilly is planning on reorganizing its approach to selling drugs in the US. It will decrease the number of sales reps it employs and shift its focus towards building deeper relationships with individual physicians. It is expected that this reorganization will help Eli Lilly's sales …show more content…
http://www.lilly.com/products/index.html
This site is an official Eli Lilly website. It lays out all of Lilly's products and their uses.
2. http://investor.lilly.com/pipeline.cfm
This is an official Eli Lilly website. It lays out all of Eli Lilly's current drug submissions to the FDA and all drugs currently going through different FDA testing.
3. Eli Lilly. (2005). 2005 Annual Report to Shareholders. Retrieved October 20, 2005.
This is Eli Lilly's annual stockholders report. It reports on the financial data of the company for 2005, and gives predictions of its performance in 2006.
4. Quick, Amanda C., ed. Company Profiles for Students. Michigan: Gale, 2002.
This source gives financial information on Eli Lilly for 2002. It was useful in compiling a history of the company.
5. Sutton, George, ed. Hoover's Handbook of American Businesses 2002. Texas: Hoover's Business Press, 2002.
This source gives financial information on Eli Lilly for 2002. It was useful in compiling a history of the company.
6. Chuvala, Bob. (2006, August 14). Blockbuster for Biodel. Fairfield County Business Journal (Indiana). Vol. 45 No. 33 pp 1-2. Retrieved October 20, 2006 fromEBSCO Host Research